Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2014
05/15/2014US20140135496 Isoxazoline-substituted benzamide compound and pesticide
05/15/2014US20140135494 Quinoxaline Compounds and Derivatives
05/15/2014US20140135341 Pyridine And Pyrimidine Derivatives As Inhibitors Of Histone Deacetylase
05/15/2014US20140135338 Quinolinyl glucagon receptor modulators
05/15/2014US20140135328 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
05/15/2014US20140135320 Heteroaryl derivatives and uses thereof
05/15/2014US20140135309 Sulfoximine substituted quinazolines for pharmaceutical compositions
05/15/2014US20140135298 Mutation mimicking compounds that bind to the kinase domain of egfr
05/14/2014EP2729453A1 Pyrimidinone compounds and their use
05/14/2014CN103788095A 2,4(1h,3h)-嘧啶二酮衍生物及其制备方法 2,4 (1h, 3h) - pyrimidine-dione derivatives and their preparation
05/14/2014CN103788065A 一类保护移植器官的化合物及其用途 A class of compounds to protect transplanted organs and their use
05/14/2014CN103787988A 布他比妥的制备方法 Cloth than he duly prepared
05/14/2014CN103787987A 替格瑞洛中间体的制备方法 Intermediates for the preparation of 格瑞洛
05/14/2014CN103787986A 一类治疗干眼症的化合物及其用途 A class of compounds and their use treatment of dry eye
05/14/2014CN103787985A 一种二芳基嘧啶类衍生物及其制备方法和用途 A two-aryl pyrimidine derivatives and their preparation and use
05/14/2014CN103787984A 替格瑞洛中间体4,6-二氯-5-硝基-2-(丙硫基)嘧啶的制备方法 Ticagrelor intermediate 4,6-dichloro-5-nitro-2- (propylthio) pyrimidine method
05/14/2014CN103787949A 一类保护移植器官的化合物及其用途 A class of compounds to protect transplanted organs and their use
05/14/2014CN103787826A 环庚烷类化合物及含有该化合物的液晶组合物及其应用 Heptane ring compound and a liquid crystal composition containing the compounds and their application
05/14/2014CN103787802A 一类芳基烷基硫醚化合物及其合成方法 A class of aryl alkyl sulfide compounds and synthetic methods
05/14/2014CN103784458A 新型苯基丙氨酸衍生物 The new phenylalanine derivatives
05/14/2014CN102617484B 盐酸吉西他滨制备过程中胞嘧啶的回收处理方法 Recycling methods during the preparation of gemcitabine hydrochloride gemcitabine cytosine
05/14/2014CN102584716B 安立生坦的晶型及制备方法 An Lisheng Tan crystalline form and preparation methods
05/14/2014CN102197029B 作为cdk抑制剂的亚砜亚胺取代的苯胺基嘧啶衍生物、其制备以及作为药物的用途 As cdk inhibitors sulfoxide imine substituted anilino pyrimidine derivatives, their preparation and use as a medicament
05/14/2014CN102137841B 邻位取代卤代烷基磺酰苯胺衍生物及除草剂 Ortho-substituted aniline derivatives and halogenated alkylsulfonyl herbicides
05/14/2014CN102066340B 作为syk或jak蛋白激酶抑制剂的2,6-二氨基-嘧啶-5-基甲酰胺类化合物 Jak as syk kinase inhibitors, or 2,6-diamino - pyrimidin-5-yl carboxamides
05/14/2014CN102046609B 具有细胞保护效果的嘧啶衍生物及其应用 Pyrimidine derivatives having the cytoprotective effect and its application
05/14/2014CN101827949B 核碱基表征 Characterization of nucleobases
05/14/2014CN101801931B 作为二氢乳清酸脱氢酶抑制剂的氮杂联苯胺基苯甲酸衍生物 As a DHODH inhibitor aza biphenyl amino acid derivatives
05/14/2014CN101671307B 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
05/13/2014US8722695 Imidazolidinedione derivatives
05/13/2014US8722694 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
05/13/2014US8722690 Mesoionic pesticides
05/13/2014US8722687 Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
05/13/2014US8722686 Hydroxamic acid derivatives useful as antibacterial agents
05/13/2014US8722580 Agent for inhibiting cytokinin signaling
05/13/2014CA2659967C Quinazoline derivatives
05/13/2014CA2599228C Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives
05/13/2014CA2559733C Inhibitors of histone deacetylase
05/08/2014WO2014071143A1 Method for treating prostate cancer
05/08/2014WO2014068171A1 N-substituted 4-aminophenols and corresponding quinone imines
05/08/2014US20140128605 Crystals of glycine derivative and pharmaceutical use thereof
05/08/2014US20140128570 Conformationally-preorganized, minipeg-containing gamma-peptide nucleic acids
05/08/2014US20140128390 Compounds and methods for kinase modulation, and indications therefor
05/07/2014EP2727912A1 Crystals of glycine derivative and pharmaceutical use thereof
05/07/2014CN103781763A 作为钾通道阻断剂的胺衍生物 As a potassium channel blocker amine derivatives
05/07/2014CN103772373A 作为受体酪氨酸激酶抑制剂的喹唑啉类似物 As receptor tyrosine kinase inhibitors quinazoline analogs
05/07/2014CN103772357A 取代嘧啶类化合物及其用途 Substituted pyrimidines and their use
05/07/2014CN103772298A 一种盐酸厄罗替尼多晶型物及其制备方法 One kind of erlotinib hydrochloride polymorph and its preparation method
05/07/2014CN103772297A 手性六元氮杂环卡宾前体化合物及其制备方法和应用 Chiral six yuan heterocyclic carbene precursor compound and its preparation method and application
05/07/2014CN103772296A 一种喹唑啉衍生物的合成方法 A method of synthesis of quinazoline derivatives
05/07/2014CN103772295A 替格瑞洛中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法 Ticagrelor intermediate 4,6-dichloro-2- (mercapto-propyl) -5-amino-pyrimidine method
05/07/2014CN103772294A 苯氧基嘧啶胺类化合物及用途 Phenoxy-pyrimidine-amine compound and use
05/07/2014CN103772293A 含氟嘧啶类化合物及用途 Fluorinated pyrimidine compounds and uses
05/07/2014CN103772292A 一种安立生坦dmso共结晶物及其制备方法和应用 An Lisheng Tan dmso one kind of co-crystals and its preparation method and application
05/07/2014CN103772291A 含苯胺的有机半导体材料及其制备方法和有机电致发光器件 Organic semiconductor materials and preparation method containing aniline and organic electroluminescent devices
05/07/2014CN103772120A 新颖的有机电致发光化合物和使用该化合物的有机电致发光设备 Novel organic electroluminescent compounds and the use of the compound organic electroluminescent devices
05/07/2014CN102718701B 芳氧基二卤丙烯醚类化合物与应用 Dihalopropene aryloxy ether compound and Applications
05/07/2014CN102307863B 嘧啶衍生物、含该衍生物的园艺用杀虫剂及其使用方法 Pyrimidine derivatives, horticultural insecticide containing the derivatives and methods of use
05/07/2014CN102219748B 无定型安贝生坦及其制备方法 Amorphous ambrisentan and its preparation method
05/07/2014CN101679308B Hedgehog途径抑制剂 Hedgehog pathway inhibitor
05/07/2014CN101516850B 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound
05/06/2014US8716476 Process for the preparation of alfuzosin hydrochloride
05/06/2014US8716344 Class- and isoform-specific HDAC inhibitors and uses thereof
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716305 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
05/06/2014US8716297 Chemical entities to be used for Wee1 inhibition for the treatment of cancer
05/06/2014US8716285 N-hydroxy-benzamids for the treatment of cancer
05/06/2014US8716180 Method of reducing mycotoxin contamination of the harvest
05/06/2014US8715638 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/06/2014CA2644333C Reaction reagent for trifluoromethylation
05/06/2014CA2626018C 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
05/06/2014CA2612314C Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
05/01/2014WO2014066772A1 Processes and reagents for making diaryliodonium salts
05/01/2014WO2014065215A1 Transparent electrode, electronic device, and organic electroluminescent element
05/01/2014WO2014064058A1 Improved process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
05/01/2014WO2014064038A1 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
05/01/2014WO2014063642A1 Substituted pyrimidine compound and uses thereof
05/01/2014WO2014063631A1 Tyrosine kinase irreversible inhibitor and preparation method and applications thereof
05/01/2014US20140121375 Method for preparation of 5-substituted pyrimidines
05/01/2014US20140121373 Process for preparing stable polymorphic form of erlotinib hydrochloride
05/01/2014US20140121371 Processes and reagents for making diaryliodonium salts
05/01/2014US20140121224 Quinazolinones as inhibitors of human phosphatidyositol 3-kinase delta
05/01/2014US20140121223 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
05/01/2014US20140121221 Selective pde4 b inhibition and improvement in cognition in subjects with brain injury
04/2014
04/30/2014EP2725015A1 Uracil or thymine derivative for treating hepatitis c
04/30/2014EP2723722A1 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl (2,3,4,5,6-pentahydroxyhexyl) amino) ethoxy) phenyl) butyl) carbamimidoyl) pyrazine-2-carboxamide
04/30/2014EP2723332A1 Novel compounds as diacylglycerol acyltransferase inhibitors
04/30/2014CN103764633A 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl (2,3,4,5,6-pentahydroxyhexyl) amino) ethoxy) phenyl) butyl) carbamimidoyl) pyrazine-2-carboxamide
04/30/2014CN103764632A Co-crystals of cyprodinil and dithianon
04/30/2014CN103764164A Production of dense bodies (db) from hcmv-infected cells
04/30/2014CN103755649A Quinazoline derivative and application thereof as vasculogenesis inhibitor
04/30/2014CN103755648A New impurity of gefitinib and preparation method thereof
04/30/2014CN103755647A C2-bit derivative of 4(3H)-quinazolinone and preparation method and application thereof
04/30/2014CN103755646A Quinazolinyl chalcone derivatives, and preparation method and application thereof
04/30/2014CN103755645A Synthetic process of compound pyrrole alkyl amino pyrimidine oxide
04/30/2014CN103755644A Compound as well as synthesis thereof and method for synthesizing double-UPy substituted compound by using same
04/30/2014CN103755643A Rosuvastatin calcium I crystal form
04/30/2014CN103755505A Method for synthesizing benzyl alkyl sulfur ether
04/30/2014CN102369009B Co-crystal of etravirine and nicotinamide
04/29/2014US8710261 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 427